Ru Wen
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Glycosylation and Glycoproteins Research 4
- RNA Interference and Gene Delivery 3
- ATP Synthase and ATPases Research 3
- Mitochondrial Function and Pathology 3
- Immunology 10
- Immunotherapy and Immune Responses 6
- Galectins and Cancer Biology 2
- Co-authors
- Shanta Dhar (6 shared papers)Jian Xu (2 shared papers)Rakesh Pathak (3 shared papers)Afoma C. Umeano (6 shared papers)Bhabatosh Banik (3 shared papers)Ammad Ahmad Farooqı (3 shared papers)Nagesh Kolishetti (3 shared papers)Wenjuan Liu (1 shared paper)
- Journals
- Cancer Research (3 papers)International Journal of Molecular Sciences (2 papers)Journal of Cellular Biochemistry (1 paper)Advanced Therapeutics (1 paper)International Journal of Surgery (1 paper)
- Partner nations
- United StatesChinaPakistan
In The Last Decade
Ru Wen
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Biomaterials 182
- Immunology 246
- Cancer Research 115
- Molecular Biology 513
- Oncology 184
Countries citing papers authored by Ru Wen
This map shows the geographic impact of Ru Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Wen more than expected).
Fields of papers citing papers by Ru Wen
This network shows the impact of papers produced by Ru Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Wen. The network helps show where Ru Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ru Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 172 | |
| 2 | 2019 | 149 | |
| 3 | 2019 | 149 | |
| 4 | 2019 | 111 | |
| 5 | 2016 | 110 | |
| 6 | 2016 | 89 | |
| 7 | 2018 | 86 | |
| 8 | 2017 | 56 | |
| 9 | 2020 | 49 | |
| 10 | 2018 | 35 | |
| 11 | 2018 | 30 | |
| 12 | 2016 | 19 | |
| 13 | 2017 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2022 | 16 | |
| 17 | 2014 | 15 | |
| 18 | 2022 | 13 | |
| 19 | 2017 | 12 | |
| 20 | 2016 | 11 |
About Ru Wen
Ru Wen is a scholar working on Molecular Biology, Immunology, Biomaterials, Biomedical Engineering and Oncology, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers), Glycosylation and Glycoproteins Research (4 papers), RNA Interference and Gene Delivery (3 papers), ATP Synthase and ATPases Research (3 papers), Mitochondrial Function and Pathology (3 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Biomaterials (182 citations), Immunology (246 citations), Cancer Research (115 citations), Molecular Biology (513 citations) and Oncology (184 citations). Ru Wen has collaborated with scholars based in United States, China and Pakistan. Frequent co-authors include Shanta Dhar, Jian Xu, Rakesh Pathak, Afoma C. Umeano, Bhabatosh Banik, Ammad Ahmad Farooqı, Nagesh Kolishetti, Wenjuan Liu, Ming Yang and Yue Du. Their work appears in journals such as Cancer Research, International Journal of Molecular Sciences, Journal of Cellular Biochemistry, Advanced Therapeutics and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.